Literature DB >> 1716045

Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine.

J M Lemire1, N Shiojiri, N Fausto.   

Abstract

Oval cells may function as facultative liver stem cells and tumor progenitors in liver carcinogenesis. The authors determined whether oval cells proliferate and if small hepatocytes might be generated from epithelial cell progenitors in noncarcinogenic liver injury. The authors found that oval cells similar to those detected in early carcinogenesis proliferate in response to D-galactosamine (GaIN). Oval cells expressed gamma-glutamyl transpeptidase activity, bile duct-type cytokeratins and peanut agglutinin binding. Two unusual types of hepatocytes also appeared after injury: small hepatocytes (less than or equal to 16 microns in diameter) and hepatocytes lining atypical ductlike structures. In situ hybridization studies showed that the fetal form of alphafetoprotein mRNA was expressed by many oval cells, some bile duct cells, and occasional hepatocytes. By following the fate of epithelial cells labeled early after GaIN administration, the authors conclude that duct cells can generate both oval cells and small hepatocytes in response to GaIN.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716045      PMCID: PMC1886213     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

Review 1.  Hepatocyte differentiation and liver progenitor cells.

Authors:  N Fausto
Journal:  Curr Opin Cell Biol       Date:  1990-12       Impact factor: 8.382

2.  Significance of the so-called oval cell proliferation during azo-dye hepatocarcinogenesis.

Authors:  Y Inaoka
Journal:  Gan       Date:  1967-08

3.  Rat alpha 1-fetoprotein: appearance after galactosamine-induced liver injury.

Authors:  S Sell; R D Reynolds; W Reutter
Journal:  J Natl Cancer Inst       Date:  1974-07       Impact factor: 13.506

4.  Ultrastructural features in galactosamine-induced hepatitis.

Authors:  A Medline; F Schaffner; H Popper
Journal:  Exp Mol Pathol       Date:  1970-04       Impact factor: 3.362

5.  Liver restitution after acute galactosamine hepatitis: autoradiographic and biochemical studies in rats.

Authors:  R Lesch; W Reutter; D Keppler; K Decker
Journal:  Exp Mol Pathol       Date:  1970-02       Impact factor: 3.362

6.  Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity.

Authors:  A M Rutenburg; H Kim; J W Fischbein; J S Hanker; H L Wasserkrug; A M Seligman
Journal:  J Histochem Cytochem       Date:  1969-08       Impact factor: 2.479

7.  Light- and electron-microscopic autoradiographic analysis of proliferating cells during the early stages of chemical hepatocarcinogenesis in the rat induced by feeding N-2-fluorenylacetamide in a choline-deficient diet.

Authors:  S Sell; J Salman
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

Review 8.  Cell types in long-term propagable cultures of rat liver.

Authors:  J W Grisham
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

Review 9.  Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma.

Authors:  S Sell; H A Dunsford
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  79 in total

Review 1.  Differential growth: from carcinogenesis to liver repopulation.

Authors:  E Laconi
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  The facultative stem cell: A new star in liver pathology.

Authors:  Peter Nagy
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

3.  Cellular origin of regenerating parenchyma in a mouse model of severe hepatic injury.

Authors:  K M Braun; E P Sandgren
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

4.  Differential expression of the rat gamma-glutamyl transpeptidase gene promoters along with differentiation of hepatoblasts into biliary or hepatocytic lineage.

Authors:  N Holic; T Suzuki; A Corlu; D Couchie; M N Chobert; C Guguen-Guillouzo; Y Laperche
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

5.  Liver damage using suicide genes. A model for oval cell activation.

Authors:  M Bustos; B Sangro; P Alzuguren; A G Gil; J Ruiz; N Beraza; C Qian; A Garcia-Pardo; J Prieto
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

6.  Evaluation of the differentiation potential of WB-F344 rat liver epithelial stem-like cells in vivo. Differentiation to hepatocytes after transplantation into dipeptidylpeptidase-IV-deficient rat liver.

Authors:  W B Coleman; K D McCullough; G L Esch; R A Faris; D C Hixson; G J Smith; J W Grisham
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

7.  Bile ductular damage induced by methylene dianiline inhibits oval cell activation.

Authors:  B E Petersen; V F Zajac; G K Michalopoulos
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 8.  Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.

Authors:  Pooja Chaudhari; Lipeng Tian; Abhijeet Deshmukh; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

9.  The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3.

Authors:  David Cassiman; Louis Libbrecht; Nicoletta Sinelli; Valeer Desmet; Carl Denef; Tania Roskams
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

10.  Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment.

Authors:  W B Coleman; A E Wennerberg; G J Smith; J W Grisham
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.